Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0221002 (
primary hyperparathyroidism
)
4,921
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Patients with
primary hyperparathyroidism
are often elderly with cardiovascular disease and in some an operation might be hazardous owing to anaesthetic complications. A technique for operation for
primary hyperparathyroidism
under local anaesthesia is described. The method uses a unilateral approach. Seventeen consecutive patients operated on under local anaesthesia were compared with a group of 15 patients undergoing surgery under general anaesthesia. Normocalcaemia was achieved in 14 patients in each group. There was no difference in the extent of pain or the overall well-being between the two groups as determined by a visual analogue scale. Patients receiving local anaesthesia, however, experienced significantly less nausea after operation (P < 0.01). There was more fluctuation in blood pressure and heart rate in the general anaesthesia group compared with the other group. Surgery for
primary hyperparathyroidism
can be performed safely under local anaesthesia, and could be offered to patients if general anaesthesia were not suitable or involved an increased perioperative risk. It should not be recommended for routine use in patients who are fit for general anaesthesia.
Br J Surg 1992
Sep
PMID:Surgery for primary hyperparathyroidism performed under local anaesthesia. 142 61
Hypercalcemia may occur as a complication of haematological malignancies, in association with solid tumors with bone metastases, and with solid tumors in the absence of bone metastases. The latter syndrome, known as the humoral hypercalcemia of malignancy (HHM) shares many features with
primary hyperparathyroidism
. A parathyroid hormone-related protein (PTHrP) has been identified, isolated and cloned, which is most likely responsible for the calcium disturbances in HHM, PTHrP is a previously unrecognized hormone which has limited amino-terminal sequence homology with PTH and is the product of a separate gene. Tissue localization studies have identified PTHrP in squamous cell carcinomata, renal cortical carcinomata, in a proportion of breast cancers and in adult T-cell leukemia/lymphoma. In normal tissues, PTHrP has been immunohistochemically localized in keratinocytes, placenta and fetal parathyroid glands. In addition to its role in mediating hypercalcemia in cancer, PTHrP is likely to have an important endocrine role in the fetus, and perhaps a paracrine function in several organs.
J Steroid Biochem Mol Biol 1992
Sep
PMID:Hypercalcemia in cancer. 152 53
Nineteen patients with histologically confirmed parathyroid adenomas were studied immediately before and 12 months after operation. The concentrations of 37 amino acids were estimated by chromatography in plasma and urine. In addition, proximal tubular function was studied by measuring the excretion of beta 2-microglobulin. No general aminoaciduria was registered either before or after operation but there were variations between preoperative and postoperative values in the plasma and urinary concentrations of a few amino acids. There were no correlations between preoperative and postoperative concentrations of calcium, parathyroid hormone or the various amino acids in plasma or urine. Nor was there any between the fall in serum calcium and the concentrations of the amino acids. There was no correlation between glomerular filtration rate and the amount of the different amino acids filtered. beta 2-Microglobulin excretion was normal both before and after operation in all but one patient. Aminoaciduria does not seem to be present in primary hyper-parathyroidism. Plasma and urinary concentrations of amino acids were unchanged after parathyroidectomy and proximal tubular function, assessed by measuring concentrations of amino acids in plasma and urine and urinary excretion of beta 2-microglobulin does not seem to be affected in
primary hyperparathyroidism
.
Eur J Surg 1991
Sep
PMID:Plasma and urinary amino acids as indicators of proximal tubular function in primary hyperparathyroidism. 168 72
A 57-year-old man had renal stones, and biochemical investigation led to a diagnosis of
primary hyperparathyroidism
. Surgical exploration revealed bilateral inferior parathyroid enlargement. Both glands were removed; macroscopically, small cysts were seen on cut sections. Histologic examination showed broad bands of fibrosis, lymphoid follicles, and plasma cells that diffusely effaced the parathyroid architecture. Such features--if seen in the thyroid gland--would be reminiscent of an autoimmune process. The cysts were lined by respiratory and squamous epithelia and contained lymphoid follicles in their walls. Less affected areas of the parathyroid tissue were hyperplastic. It is believed that the inflammatory response in the parathyroid glands that is described in this article may be characteristic. It may result from the cysts or their contents or from an autoimmune reaction.
Am J Clin Pathol 1991
Sep
PMID:Parathyroiditis associated with hyperparathyroidism and branchial cysts. 171 27
A case of acute pancreatitis associated with
primary hyperparathyroidism
is reported. There was none of usual causes of pancreatitis, which did not recur following the removal of a parathyroid adenoma. There are over one hundred of cases of acute or chronic pancreatitis associated with hyperparathyroidism in the literature, suggesting a causal relationship between the two entities. The pancreatic disease has been attributed either to the hypercalcemia or to the excess of circulating parathyroid hormone. However, some authors have recently questioned any link between these two diseases.
Rev Esp Enferm Dig 1991
Sep
PMID:[Acute pancreatitis associated with primary hyperparathyroidism]. 175 Oct 69
The incidence of
primary hyperparathyroidism
was determined in 4000 renal stone formers treated by ESWL at our institution from 1983 to 1990. Based on repeated measurements of serum calcium and serum parathyroid hormone an incidence of 2.8% was found. In 60% of patients with
primary hyperparathyroidism
stone disease occurred for the first time. The majority of patients (68%) were more than 50 years of age. 56% of patients were men, 44% were women.
Helv Chir Acta 1991
Sep
PMID:[Primary hyperparathyroidism: studies of 4,000 urinary calculi patients treated with extracorporeal shockwave lithotripsy]. 176 54
Nine patients (median age, 81 years) with
primary hyperparathyroidism
were treated with intravenous infusions of disodium pamidronate (APD), which is a bisphosphonate drug. Six patients had severe hypercalcemia (serum calcium concentration, greater than 3 mmol/L) persisting after rehydration with saline and treatment with furosemide; three patients had moderate hypercalcemia with pronounced symptoms (serum calcium concentration 2.8 to 2.9 mmol/L). Three of the patients were considered to have hypercalcemic crises. In all patients, the raised serum calcium levels were lowered by the disodium pamidronate infusions. One week after a single infusion of 15 to 60 mg disodium pamidronate, six of the nine patients had serum calcium concentrations within the normal reference interval and two patients had slightly raised values. Transient asymptomatic hypocalcemia was noted in one patient. All patients tolerated the infusions well, and no side effects were noted. In the patients with verified parathyroid adenomas, a temporary increase in parathyroid hormone levels were observed concomitant with the drop in serum calcium level. The patient with parathyroid cancer displayed no such effect indicating an autonomous parathyroid hormone secretion from the parathyroid carcinoma tumor. The good effect of treatment with the osteoclast inhibitor disodium pamidronate on hypercalcemia caused by
primary hyperparathyroidism
suggests that this hypercalcemia is mainly due to an increased osteoclast activity. The number of patients in this series is yet too small to allow general conclusions. But the case histories in this series show that disodium pamidronate promises to be of value in different clinical situations for the treatment of severe hypercalcemia in patients with hyperparathyroidism. It can be used (1) preoperatively to investigate whether the patient's symptoms are related to the hypercalcemia, (2) in the treatment of hypercalcemic crises when "forced diuresis" has failed to normalize the serum calcium, (3) after unsuccessful parathyroid surgery when it can be used as a long-term treatment before reoperation, giving time for localization studies and healing of the scar reaction, and (4) in aged and fragile patients where it can be tried as an alternative to surgery.
Surgery 1991
Sep
PMID:Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. 848 82
For preoperative localization of enlarged parathyroid glands, several imaging techniques have been used. In this study we demonstrate the feasibility of using ultrasonography with fine needle aspiration for parathyroid hormone assay as a preoperative localization procedure in 21 patients with
primary hyperparathyroidism
. A single adenoma was found in 18 patients while 3 patients had multiglandular disease. Ultrasonically guided fine needle biopsy was possible in 11 cases. In 8 of these aspirates, a high parathyroid hormone content was found. In all 8 cases the localization was confirmed at surgery. We conclude that the efficiency to preoperatively localize enlarged parathyroid glands is enhanced by fine needle aspiration.
Acta Radiol 1991
Sep
PMID:Preoperative localization of enlarged parathyroid glands with ultrasonically guided fine needle aspiration for parathyroid hormone assay. 191 Sep 96
We studied the relationship between the bone mass and biochemical parameters in 175 normal premenopausal, 72 normal postmenopausal and osteoporotic postmenopausal women, between 20 and 88 years old, and in 40 patients with hyperthyroidism, and 23 patients with
primary hyperparathyroidism
, between 13 and 64 years old. The bone mineral density (BMD) of the spine (L2-L4) and proximal femur (femoral neck) was measured by dual-energy X-ray absorptiometry using a QDR-1000, Hologic. The bone mineral content (BMC) of the radius was measured by single photon absorptiometry (SPA) using a model 2780, Norland. Serum PTH, BGP and calcitonin (CT) were determined by radioimmunoassay. The BMD of the spine (L2-L4), and the proximal femur in postmenopausal women were negatively correlated with age. The mean BMD in patients with postmenopausal osteoporosis was significantly lower than that in normal postmenopausal women. In postmenopausal women, age was positively correlated with BGP, PTH, CT and negatively correlated with P. In patients with osteoporosis, the BMD of the spine was negatively correlated with serum BGP. The BMC of radius in patients with hyperthyroidism decreased significantly compared with that in the controls, and was negatively correlated with F-T3. The BMC of the radius in patients with
primary hyperparathyroidism
was significantly lower than that in the controls, and was negatively correlated with serum BGP and serum calcium. The measurements of biochemical parameters such as serum BGP, ALP and PTH may be useful in the assessment of metabolic bone diseases.
Rinsho Byori 1991
Sep
PMID:[Bone mass and biochemical parameters in metabolic bone diseases]. 194 67
A significant number of patients with
primary hyperparathyroidism
have negative preoperative 201Tl/99Tcm subtraction localization scans. In this study an attempt was made to improve scan localization by creating a period of relative hypocalcaemia and increased parathyroid hormone (PTH) secretion before scanning. Six patients with
primary hyperparathyroidism
were studied (mean serum calcium 2.80 mmol l-1; range 2.70-2.95). All had had a negative standard 201Tl/99Tcm scan carried out within the 6 months prior to this study. Patients were commenced on an intravenous infusion of the calcium chelating agent trisodium edetate at a dose of 24 mg kg-1 h-1 given in 500 ml 0.9% saline over 90 min. Immediately thereafter a 201Tl/99Tcm scan was carried out in the usual way. Three patients showed areas of discordant thallium uptake consistent with the presence of a parathyroid adenoma. Two of these patients had surgery and an adenoma was found at the site corresponding to the scan appearances. It would appear that creating relative hypocalcaemia and increasing PTH secretion may allow increased thallium uptake, possibly secondary to the increased cellular metabolic activity, and thus creating a positive scan.
Nucl Med Commun 1991
Sep
PMID:Augmentation of parathyroid 201Tl/99Tcm scanning by infusion of trisodium edetate. 194 90
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>